Pages that link to "Q38053557"
Jump to navigation
Jump to search
The following pages link to ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers (Q38053557):
Displaying 50 items.
- Review of current optical diagnostic techniques for non-muscle-invasive bladder cancer (Q26739731) (← links)
- Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer? (Q26744146) (← links)
- Guideline-based management of non-muscle invasive bladder cancer (Q26775975) (← links)
- Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise (Q26775990) (← links)
- Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer (Q26852084) (← links)
- Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery (Q28074930) (← links)
- Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition (Q30489708) (← links)
- Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma (Q30839472) (← links)
- Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis (Q33609364) (← links)
- Quantitative apparent diffusion coefficient measurements obtained by 3-Tesla MRI are correlated with biomarkers of bladder cancer proliferative activity (Q34155874) (← links)
- The health economics of bladder cancer: an updated review of the published literature (Q34430559) (← links)
- Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer (Q34571442) (← links)
- Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection (Q34750035) (← links)
- Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer (Q34838223) (← links)
- Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. (Q35219041) (← links)
- Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer (Q35649706) (← links)
- A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study (Q35686887) (← links)
- uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder--Possible Clinical Implications (Q35751445) (← links)
- Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis (Q35816480) (← links)
- Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study (Q35850934) (← links)
- The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient (Q36050744) (← links)
- Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study (Q36285627) (← links)
- Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests (Q36770389) (← links)
- Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma (Q37351783) (← links)
- Urinary mRNA biomarker panel for the detection of urothelial carcinoma (Q37437646) (← links)
- Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer (Q37536597) (← links)
- Urinary tract cancers: An overview for general practice (Q37623193) (← links)
- A microRNA biomarker panel for the non-invasive detection of bladder cancer (Q37699233) (← links)
- Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer (Q37706034) (← links)
- Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development (Q37714579) (← links)
- Urinary markers/cytology: what and when should a urologist use. (Q38094284) (← links)
- Urinary markers for bladder cancer (Q38122367) (← links)
- Molecular targets on the horizon for kidney and urothelial cancer (Q38132039) (← links)
- Urinary biomarkers of bladder cancer: an update and future perspectives (Q38138607) (← links)
- Urine markers for detection and surveillance of bladder cancer (Q38140308) (← links)
- Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects (Q38153435) (← links)
- The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer (Q38156070) (← links)
- Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer (Q38163897) (← links)
- Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder (Q38170812) (← links)
- New treatments for bladder cancer: when will we make progress? (Q38177753) (← links)
- MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS. (Q38188561) (← links)
- Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer. (Q38259206) (← links)
- The promise of novel molecular markers in bladder cancer (Q38298524) (← links)
- Contemporary role of advanced imaging for bladder cancer staging (Q38597003) (← links)
- Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer (Q38650676) (← links)
- Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles (Q38671095) (← links)
- Discovery of urine biomarkers for bladder cancer via global metabolomics. (Q38822316) (← links)
- Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project. (Q38887392) (← links)
- Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. (Q39010863) (← links)
- Diagnostic dilemmas in patients with upper tract urothelial carcinoma (Q39037312) (← links)